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Abstract
Background: Recruitment of participants is particularly challenging in primary care, with less than a third of randomised
controlled trials (RCT) achieving their target within the original time frame. Participant identification, consent,
randomisation and data collection can all be time-consuming. Trials recruiting an incident, as opposed to a
prevalent, population may be particularly affected. This paper describes the impact of a deferred recruitment
model in a RCT of antibiotics for children with infected eczema in primary care, which required the recruitment
of cases presenting acutely.
Methods: Eligible children were identified by participating general practitioners (GPs) and referred to a study
research nurse, who then visited them at home. This allowed the consent and recruitment processes to take
place outside the general practice setting.
Information was recorded about patients who were referred and recruited, or if not, the reasons for non-recruitment.
Data on recruitment challenges were collected through semi-structured interviews and questionnaires with a sample
of participating GPs. Data were thematically analysed to identify key themes.
Results: Of the children referred to the study 34% (58/171) were not recruited – 48% (28/58) because of difficulties
arranging a baseline visit within the defined time frame, 31% (18/58) did not meet the study inclusion criteria at the
time of nurse assessment, and 21% (12/58) declined participation. GPs had positive views about the recruitment process,
reporting that parents valued and benefitted from additional contact with a nurse. GPs felt that the deferred recruitment
model did not negatively impact on the study.
Conclusions: GPs and parents recognised the benefits of deferred recruitment, but these did not translate into enhanced
recruitment of participants. The model resulted in the loss of a third of children who were identified by the GP as eligible,
but not subsequently recruited to the study. If the potential for improving outcomes in primary care through complex
studies is to be realised, new approaches to recruitment into primary care trials need to be developed and evaluated.
Trial registration: International Standard Randomised Controlled Trials, ISRCTN96705420. Registered on 27 June 2012.
Keywords: Primary care, Randomised controlled trial, Clinical trial recruitment, Recruitment challenges, Informed consent
* Correspondence: ShepherdVL1@cardiff.ac.uk
1Centre for Trials Research, Cardiff University, Cardiff, UK
2Division of Population Medicine, School of Medicine, Cardiff University,
Cardiff, UK
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Shepherd et al. Trials  (2017) 18:533 
DOI 10.1186/s13063-017-2284-x
Background
Randomised controlled trials (RCTs) conducted in pri-
mary care settings are essential for generating the evi-
dence base required for general practice, where the
majority of healthcare is provided in the UK. However,
complex studies, such as RCTs, are often challenging
and time-consuming for participating sites, and research
projects across all settings are frequently impacted by
poor recruitment [1]. A review of multicentre trials
found that problems with recruitment were common,
complex and challenging [2]. However, it is particularly
an issue in primary care, as shown by a survey of UK
primary care studies which found that significant
recruitment difficulties were encountered, with less than
a third of studies recruiting to their original timescale
[3]. This was despite a variety of methods being used to
identify and recruit participants, such as advertisements
and screening in waiting rooms, and systematic identifica-
tion of eligible patients from practice records [3]. Barriers
encountered in RCTs in primary care settings, and strat-
egies and facilitators used to improve patient recruitment,
have been widely reported [3–5].
Trial recruitment processes vary by research questions
and the condition being investigated. Trials of preventive
strategies which recruit healthy participants will pose
different recruitment challenges than trials into the
management of patients with chronic conditions, which
in turn are quite distinct from studies in acute and
acute-on-chronic conditions [1]. The comparative diffi-
culty of recruiting an incident, as opposed to a prevalent,
population – which necessitates opportunistic clinician
referrals of patients with acute conditions – exacerbates
the problem of recruitment in primary care [6]. Insuffi-
cient time for general practitioners (GPs) to raise and
invite participation to a trial, receive informed consent,
and complete documentation during a consultation, has
been perceived as a major barrier [3, 7, 8].
A novel approach is the ‘deferred recruitment model’
(distinct from delayed consent in emergency situations)
adopted in the CREAM (Children with eczema, anti-
biotic management) study. The CREAM study was a
RCT that aimed to determine the effectiveness of orally
and topically administered antibiotics, in addition to
standard treatment with emollients and topically admin-
istered corticosteroids, on subjective and objective
eczema severity in children with clinically infected
eczema in primary care [9]. The deferred recruitment
model allowed the informed consent and recruitment
procedures and baseline data collection to take place at
a later time in the participant’s home, rather than during
the consultation. It was intended to minimise the chal-
lenges of in-consultation recruitment and to reduce the
impact for parents and young children of a prolonged
surgery visit. Whilst many approaches to recruitment in
primary care research have been described [10] a
deferred recruitment model has not previously been
reported [11].
Better understanding of facilitators and barriers to re-
cruitment, including the impact of trial design, is essen-
tial to develop effective approaches to recruitment [12].
The gap in knowledge and evidence for effective
recruitment strategies has been reported, alongside the
recommendation for trialists to include evaluations of
their recruitment strategies in order to improve the con-
duct and efficiency of future trials [13]. Evidence from
recruitment methods used in practice, such as presented
here, may be helpful when planning similar studies,
together with the development of an evidence-based,
practical framework for recruitment in primary care [14].
Methods
Details of the CREAM study are described elsewhere [9].
General practices (n = 95) and dermatology clinics (n = 4)
were recruited as sites. Potentially eligible children with a
history of eczema were identified by GPs, or in primary
care dermatology clinics, from their patient lists and their
parents were informed by letter that the practice was
taking part in the study. If the child presented with
suspected infected eczema, and the GP confirmed that
they were eligible for the study (Appendix: Inclusion and
exclusion criteria) their parents received further informa-
tion, including the Participant Information Sheet. If they
were willing to take part, the GP referred them to the local
CREAM study research nurses. GPs completed a referral
proforma and a prescription for the trial medication which
the parent signed to indicate that they were willing to be
referred. These were faxed to the co-ordinating centre and
the designated clinical trial pharmacy, respectively. The
child was also prescribed a moderately potent topically
administered corticosteroid and an emollient.
Research nurse support was provided from research
networks and research nurses employed specifically for
the trial. Research nurses arranged a baseline visit to the
participant’s home within a specified time frame. Due to
concerns about children with infected eczema waiting to
be seen by the research team, this was initially 48 h from
referral by the identifying site. However, concerns about
complications within this time frame were not realised
and in order to be able to recruit patients identified on a
Friday and optimise recruitment, the maximum time
was increased to 72 h from receipt of the referral. How-
ever, the aim was to visit most children within 24 h.
Potential participants were randomised to one of three
study arms by a study pharmacy: orally and topically
administered placebos, orally administered flucloxacil-
lin and topically administered placebo, or topically
administered fusidic acid and orally administered
placebo, for 1 week.
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The baseline visit by the research nurse included
providing information about the study, checking eligibil-
ity, obtaining informed consent, completing a clinical
assessment and taking swabs, completing questionnaires,
and arranging follow-up visits. The research nurse would
collect the trial medication from the clinical trials phar-
macy prior to the baseline visit, and would release this
to the parent following provision of informed consent
with an explanation of how to use the treatments.
Participating general practices were spread across wide
geographical areas, which necessitated research nurses
travelling from their base (or previous participant visit),
to the centralised pharmacy which dispensed the trial
medication, and then out to the participant’s home.
The baseline visit took up to 2 h to complete, and it
was thought that young children may be more at ease
and compliant with clinical assessments if this was
undertaken in their home environment. It was antici-
pated that a visit to the child’s home would be more
convenient for parents, which would likely be considered
a positive feature of the study when GPs were inviting
parents to take part.
The delay from referral to recruitment of up to 72 h
necessitated a confirmation at the time of consent that
the child’s eczema had not worsened, requiring an
urgent review of their management, or that any other
change had occurred that rendered them ineligible. A
referral faxed by a GP surgery after ‘office hours’ was
received by the trial team the following morning, which
may mean the baseline visit occurred early on the 4th
calendar day in some cases. It was the referring clini-
cian’s responsibility to decide whether it was safe and
appropriate to refer a child on a Friday, knowing they
would not be seen by a research nurse over the weekend.
Follow-up visits at 2 and 4 weeks were also conducted
in the participant’s home usually by the same research
nurse, with 3-month follow-up conducted via parent-
completed postal questionnaire and swabs and a primary
care medical records search.
Participating clinicians were asked to keep screening
logs to record information about patients referred to the
study team. Research nurses also recorded details about
whether patients referred to the study team were
recruited and, if not, the reasons for non-recruitment.
Data were not recorded on the number of attempts
made to contact parents, the time period between refer-
ral and contact by the research nurse, or the time
between referral and a decision not to participate.
Data on recruitment challenges were collected through
a combination of semi-structured, audio-recorded tele-
phone interviews and semi-structured questionnaires.
We identified a purposive sample of general practices
that had recruited the highest numbers of participants
(recruited three or more participants) (n = 4), low
recruiting practices (recruited one to three participants)
(n = 6), and practices that were engaged but had not
recruited any participants (n = 3), across English and
Welsh sites. The principal investigator (a GP) at each
site was contacted and invited to participate in a short
telephone interview. Those who we were not available
for interview were invited to complete a semi-structured
questionnaire to be returned by post or email.
Those practices that reported that they were unable to
respond formally (due to time or other resource issues)
were asked to provide informal feedback either by email or
telephone conversation. This informal feedback supported
the findings from analysis of the interview and question-
naire data. Research nurse field notes, regular documented
meetings and opportunistic feedback from GPs and other
stakeholders were also used as data sources.
An interview topic guide defined the main topics,
whilst allowing flexibility to pursue issues in more depth
as they emerged from the interviews. Interviews were
audio-recorded and transcribed verbatim. We used post
hoc descriptive analysis to evaluate the impact of the
recruitment model.
Results
Of the 95 sites that were initiated only 35% (32 GP sites
and one dermatology clinic) actively recruited one or
more participants into the study. A total of 171 children
were identified by participating clinicians and referred to
the study, and of these, 113 (66%) were recruited. Four
patients (4%) were recruited from primary care derma-
tology clinics, 109 (96%) came from general practices.
The median referral to recruitment interval was 1 day
(57% same day, 12% 1 day, 10% 2 days, 7% 3 days, 14%
4 days). Of the 34% (58/171) of patients referred to the
study who were not recruited, all were referred from
general practices (Fig. 1).
Ineligibility of children
Of the children who were referred but not recruited,
31% (18/58) were identified by the research nurse as not
meeting the study inclusion criteria either at the initial
telephone consultation (94% 17/18) or at the baseline
visit (6% 1/18) prior to consent and registration.
The most frequent reason for ineligibility was the
recent use of antibiotics or potent or very potent
corticosteroids, which accounted for 15% (9/58) of those
referred by clinicians but not recruited.
Unable to participate due to time and resource issues
Almost half of those not recruited were because of
difficulties in arranging a baseline visit 48% (28/58). This
included cases where parents were either not contactable
by the research nurse (29% 8/28) or were unavailable for
a baseline visit for unknown reasons (11% 3/28). Of
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children referred and not recruited, 16% (9/58) were not
recruited because the research nurse was unable to
arrange the baseline visit within the agreed time frame
as the parents were not available. Reasons provided for
the unavailability of the parent included work commit-
ments (78% 7/9), family holidays (11% 1/9), and the
child being in school or childcare during the period that
a baseline visit would need to be conducted within (11%
1/9). An additional 29% (8/28)) of children were not
recruited because research nurses reported a lack of time
or resources. Where reasons were provided, the main
reasons given for research nurse unavailability were
conflicting study appointments (25% 2/8), and the
amount of time required to allow for dispensing and
collection of the study medication from the hospital
pharmacy prior to the visit (25% 2/8).
Parents declined participation
Of those children who were referred but were not
recruited, 21% (12/58) were not recruited because their
parents decided that they did not wish to participate.
More than a third (42%, 5/12) of those who did not wish
to take part cited that they were not willing to use anti-
biotics as the reason for their decision. These parents
did not appear to have a complete understanding of the
study when they were referred by their clinician, and
declined upon receiving information that the study was
evaluating the use of antibiotics. Two parents (17% 2/
12) indicated that they had changed their mind about
participating in the study. Two parents (17% 2/12)
reported that the child’s eczema had improved from the
initial consultation to an extent that they no longer
wished to take part in the trial. This improvement was
attributed to the use of standard steroid and emollient
care during the period from referral to contact by the
research nurse.
Views of participating GPs
Eight GPs from practices with high recruitment (2), low
recruitment (3) and no recruitment (3), contributed
qualitative data (three interviews, five semi-structured
questionnaires). Three GPs felt very positively about the
research nurse visit as part of the study design, which
was described as an ‘important’ aspect. Several GPs
reported that they had received feedback from parents
that they liked the home visit, which they perceived as
‘specialist care in their own homes’, particularly when the
research nurse had a dermatology background. Parents
felt that they benefitted from additional contact with a
knowledgeable healthcare professional that they would
not have received if they had not participated in the
study. Participating GPs reported that the deferred
recruitment model did not impact negatively on the
study. One practice reported that having more research
nurse time available would have been beneficial to
recruitment at their practice.
The additional administrative burden that resulted
from referral to the study team for deferred recruitment
was explored. The requirement to complete two
prescriptions, a routine prescription for a corticosteroid
and an emollient, and a study-specific prescription for
study medication (which was then faxed to the site phar-
macy) was reported as problematic by several GPs. The
plan had been for study documents to be transmitted
Fig. 1 Participants referred and not recruited. Children were assessed by a clinician for eligibility for the trial, and were subsequently either recruited or
not recruited to the trial. Data are shown as number of children who were assessed, and recruited or not recruited. Data for children not recruited are
shown divided by category, and expressed as a percentage of children not recruited
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electronically, but we encountered significant problems
with the specialist software designed to do this, and the
software was eventually withdrawn, necessitating the use
of fax to transmit documents. This was particularly
burdensome as the study prescription needed to be
faxed to the site pharmacy and other documents needed
to be faxed to the study team. GPs did not think that re-
cruitment being conducted outside the practice by exter-
nal personnel had reduced practice ‘buy in’ to the study,
although a lack of awareness about the study among the
practice team was commonly found during research
team visits and telephone contact with practices.
Informal feedback obtained from participating GPs
and practices supported these findings, with practices
commonly citing the low numbers of children consulting
with suspected infected eczema and the difficulty of
defining infection and eligibility as resulting in low rates
of recruitment.
Management of resources
The trial was resource intensive, requiring significant levels
of research nurse support. The balancing of opportunistic,
unplanned referrals, narrow time windows for completing
baseline visits, the time required for dispensing study
medication, and travel time to a participant’s home often
made it difficult to arrange baseline appointments. Our
recruitment rate was lower than anticipated and
unplanned recruitment visits needed to be arranged at
short notice; therefore, balancing research nurse workflow
and available personnel was challenging. As different
models of research nurse support were used in different
regions, requirements and available support were deter-
mined for each region, and required a degree of flexibility
and modification.
Difficulties arose when referrals were received from
clinicians prior to the weekend or public holidays.
Research nurses endeavoured to contact parents at the
earliest opportunity. Out-of-hours’ visits were rarely
possible due to the restriction of clinical trial pharmacy
opening times.
Discussion
The deferred recruitment model – using research nurses
to recruit participants in the days following identification
in general practice – helped reduce the burden for GPs,
but may have hindered recruitment potential in other
ways. Whilst it helped to address the issue of practice
staff not having the time or flexibility to be able to con-
duct the 2-h baseline assessment, which would also
require training staff in multiple practices to conduct
assessments, it resulted in loss between identification
and recruitment and may have deterred some parents
from participating. These events may have been less
likely if the child was recruited into the study in the
practice on the day of the consultation.
It is difficult to compare recruitment rates in this trial
and other trials in primary care due to the distinctive
features of the trial – a clinical trial of a medicinal prod-
uct in a paediatric population, requiring recruitment
during incidence of infection in a primary care setting.
Alternative models of recruitment used in prevalence or
registry-based studies, such as prior parental consent for
children diagnosed with eczema in participating prac-
tices or self-referral, could have been considered. How-
ever, neither of these approaches are likely to have been
feasible in this study. Consenting all children with
eczema would have been problematic, as only a very
small proportion would have been likely to become
eligible during the trial period. Similarly, self-referral to
the trial would have been problematic given the need for
the diagnosis to be confirmed clinically, and the need for
prescribed corticosteroid and emollient treatment and
trial medication.
Arranging a baseline visit at a convenient time for
both parents and study personnel, and within the time
frames specified in the protocol, was problematic.
Parents’ willingness to be referred to the study team did
not necessarily reflect their intention to participate in
the trial, which may have been due to an incomplete
understanding about the study. It has been reported
elsewhere that there has been a shift from parents’
expectation and demand for antibiotics when their child
is unwell to concerns regarding antibiotic resistance
related to unnecessary prescribing [15]. This may be a
result of awareness campaigns about the links between
antimicrobial use and antimicrobial resistance [16].
We were limited to practices that were within travel-
ling distance of research nurses and clinical trials phar-
macies. The short shelf-life of the oral preparations once
reconstituted (7 days) required same-day delivery to trial
participants. However, dispensing procedures meant that
participating clinical trials pharmacies required a mini-
mum of 2–4 h notice prior to a baseline visit. This time
was longer than for routine dispensing of orally adminis-
tered antibiotics as clinical trial pharmacies are based in
large teaching hospitals that commonly experience high
dispensary workloads, and additional documentation
and processes are required when dispensing an investi-
gational medicinal product. This was a major challenge
in terms of recruiting practices and participants, and led
to difficulties in expanding the study.
Ethical and methodological concerns may have been
raised about randomisation and allocation of the trial
medication occurring prior to written consent to partici-
pate (although the parent had consented to their child
being referred to the study); however, these concerns
were not realised. No concerns were raised by the
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Research Ethics Committee during their review, and a
favourable ethical opinion was obtained. The trial design
ensured that the research nurse only released the trial
medication once informed consent had been obtained
and a consent form signed. At the conclusion of the
trial, it remained sufficiently balanced in terms of alloca-
tion between trial arms [9].
In terms of health and well-being concerns, there were
only two incidents of children who required further
consultation with their GP between referral and recruit-
ment, and were subsequently prescribed antibiotics and
not recruited. Therefore, the recruitment method is
unlikely to have affected our measure of treatment effect.
No serious adverse events were recorded during the trial.
Limitations
We did not evaluate the model as part of a formal ran-
domised evaluation of its effectiveness. A formal process
evaluation or qualitative analysis did not form part of
the original study design, so the findings presented here
only report on available data. As practices did not reli-
ably record details of potentially eligible children
screened or reviewed in their practices, there are no data
regarding children who consulted their GP for infected
eczema and were not referred because they were ineli-
gible at the time of consultation or whose parents were
not interested in taking part. Due the comparatively
small number of children recruited from dermatology
clinics, comparisons between the different models of re-
cruitment in the two settings cannot be made.
Reasons recorded for referred children not being
recruited are limited in scope, with no reason recorded
for the ineligibility or non-participation of some chil-
dren, in some cases perhaps because the reason was not
known or as a result of detailed reasons not being
recorded where contact was made. There are many
possible reasons that the parents of eight of the children
may have been uncontactable, including that they
decided not to participate. Reasons for deciding not to
participate may have included discussion with another
person, improvement of the child’s eczema, or other
treatment being sought following referral. Some reasons
for not participating, such as due to an incomplete
understanding of the study, may have occurred regard-
less of whether there was a delay in recruitment or not.
As there are no data regarding the eczema severity or
extent for children who were not recruited and, there-
fore, did not provide baseline data, the characteristics of
participants versus non-participants cannot be com-
pared. There may have been GP-specific effects on re-
cruitment or non-recruitment of children presenting,
including their degree of equipoise, the quality of infor-
mation provided to potential participants, and any differ-
ential effects on the application of eligibility criteria. We
did not record the time period between referral and ini-
tial contact by the research nurse; therefore, we cannot
determine if there is an association between the length
of time between contact and whether the child was re-
cruited or not.
A relatively small number of number of GPs were
involved in the evaluation. The GPs participating in
interviews and returning questionnaires were more likely
to be engaged with the study and responsive to
approaches from the study team. This may have affected
clinician and parent perception of the study in those
practices as a consequence.
GPs’ views on alternative recruitment models, such as
GPs obtaining informed consent during the consultation
with research nurses conducting the baseline assess-
ments at a subsequent appointment, were not explored.
Recommendations
With increasing demands on primary care and a short-
age of clinicians, alternative strategies to minimise the
burden of recruitment and consent processes for GPs
are urgently required. Although deferred recruitment
was seen as acceptable and welcome by the GPs partici-
pating in our evaluation, a large proportion of patients
identified and referred in to the study were lost.
Although participants seemed to value the additional
time and expertise that a nurse was able to give them,
this could perhaps be done alongside a GP consultation
in a practice setting. GP surgeries may have found it
difficult to conduct a baseline appointment during the
consultation, given the time required to complete all the
assessments. However, GPs obtaining informed consent
during the consultation, followed by referral to the
research nurse for a subsequent baseline assessment
visit, may have improved the recruitment process. The
follow-up visits being conducted by research nurses in
the participants’ homes at 2 and 4 weeks may confer the
benefit of ongoing eczema advice that was generally
considered as a facilitative factor by both GPs and par-
ents, without restriction from the narrow time frame
required at the time of recruitment.
Methods that enable primary care studies to recruit
opportunistically during consultations need to be devel-
oped, especially for low-risk comparative effectiveness
studies that compare existing licensed technologies/
products. Recent primary care trials have demonstrated
that it is possible to both recruit and randomise young
children with eczema during a consultation, but that
retention rates may be lower [17] and recruitment more
problematic [18] using in-consultation pathways when
compared with other models. Consent procedures and
documentation could be simplified for pragmatic studies
involving medicines with a well-established safety profile.
However, the ethical, regulatory and practical issues
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would require careful exploration. Much of the baseline
data collected are already collected by clinicians and
would be relevant to their clinical assessment and med-
ical record keeping. Systems to facilitate the electronic
capture of this information and integrate it with the
medical record would be of value to clinicians and
researchers. Further exploration of recruiting clinicians
and participants’ views on alternative models of consent
and recruitment, such as deferred recruitment, in other
conditions and with different study designs is required.
Further assessment of this model through a randomised
evaluation may be warranted.
Conclusions
Several recruitment issues were encountered in this
study, including the loss of potential participants in
primary care between identification and recruitment. A
key decision in the design of the trial was to have
research nurses visit potential participants at home in
order to minimise the burden for participating GPs to
gain consent, which had been found elsewhere to be a
barrier to recruitment.
The requirement to complete the baseline visit within
a short time frame, to maintain the safety of participants
and provide accurate baseline data, was a barrier.
Despite research nurses offering flexible appointments,
difficulties arranging baseline visits remained if the child
was of school age and well enough to attend school, or
parents had work commitments, due to the length of
time needed for a baseline visit and the need to assess
the child’s skin and take swabs during the visit.
Alternative strategies to minimise the burden of
recruitment and consent processes for GPs, particularly
during routine consultations, are urgently required in
order to address the challenges of recruitment to clinical
trials in primary care.
Appendix
Inclusion and exclusion criteria
Children were eligible to join the study if they met the
following inclusion criteria and did not meet any of the
exclusion criteria:
Inclusion criteria:
Children (aged 3 months to less than 8 years) with atopic
eczema who presented with a clinical suspicion of infected
eczema. This could include children where:
The eczema was failing to respond to standard treatment with
emollients and/or mild-to-moderately potent topically administered
corticosteroids
There was a flare in the severity or extent of the eczema
There was weeping or crusting
Exclusion criteria
(Continued)
Children were not eligible for inclusion if they had:
Used orally or topically administered antibiotics to treat a skin
infection within the past week
Used potent or very potent topically administered corticosteroids
within the past 2 days
Features suggestive of eczema herpeticum (significant pain,
punched out lesions)
Known significant comorbid illness (e.g. significant immune
compromise)
Allergy to fusidic acid or both penicillin and erythromycin
Contraindication to any study medication (penicillin, erythromycin,
fusidic acid)
A treating clinician that believed the patient had a severe infection
requiring immediate antibiotics or was arranging immediate
hospitalisation or urgent (same or next day) dermatology referral
because of the severity of the eczema or suspected infection
A parent/legal guardian was unable to provide written informed
consent
A parent/legal guardian (or a person delegated by the parent/legal
guardian) was not available for follow-up visits and who did not under-
stand English well enough to complete verbal and written
questionnaires
Abbreviations
GP: General practitioner; RCT: Randomised controlled trial
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